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T he majority of cases of congenital nephrotic syn-drome have mutations in components of glomer-
ular ﬁltration barrier especially nephrin and podocin.
Mutations in genes highly expressed in podocytes have
been found in two-thirds of patients presenting with
steroid-resistant nephrotic syndrome in the ﬁrst year of
life.1–4 Mutations in 7 genes (NPHS1, NPHS2, CD2AP,
PLCE1, ACTN4, TRPC6, and INF2) are implicated in
different forms of nonsyndromic steroid-resistant
nephrotic syndrome.2 We report a rare family with
multiple cases of congenital nephrotic syndrome, with
all of them progressing to end-stage renal disease during
infancy.
CASE PRESENTATION
A 4-month-old boy presented at our clinic with acute
gastroenteritis and anasarca, with the latter beginning
at 2.5 months of age, and worsening progressively due
to nephrotic range proteinuria. The child was born full
term to an Indian family. He had a family history of
anasarca that progressed to renal failure and death of 2
siblings at the age of 2 years and 9 months, respectively
(Figure 1). Both siblings had early onset at around 2
months of life with anasarca. Laboratory parameters are
shown in Table 1.
Kidney biopsy was done to underpin the etiology of
his congenital nephrotic state. Light microscopy
revealed 12 glomeruli, of which 8 were completely
sclerosed with podocytic hyperplasia. Examination of
the tubulointerstitial compartment showed patchy
tubular atrophy, interstitial inﬂammation, and ﬁbrosis
involving 20%–25% of the cortex sampled. There was
marked microcystic dilation of the tubules withInternational Reports (2016) -, -–-occasional broad hyaline cast (Figure 2). Immunoﬂuo-
rescence was negative for Igs and complement. Electron
microscopy revealed diffuse podocyte foot process
effacement with focal areas of podocytic detachment
and glomerular basement membrane wrinkling. Mild
mesangial matrix expansion was also noted.
The diagnosis of familial congenital nephrotic syn-
drome was considered in this patient because of a
positive family history of renal failure with an auto-
somal recessive inheritance pattern and early onset of
nephrotic syndrome. Mutation analysis by Sanger
sequencing was done for NPHS1 (29 exons), WT1 (for
exons 8 and 9), and PLCE1 (31 exons). We identiﬁed a
novel homozygous nonsense mutation located in exon 7
(c.2290G>T, p.Glu764*) of the PLCE1 gene. This is
consistent with the diagnosis of autosomal recessive
steroid-resistant congenital nephrotic syndrome type 3
(NPHS3) (Figure 3). The affected child developed early
onset disease and inherited the mutation from his
asymptomatic parents who were both heterozygous
carriers.
The child received oral indomethacin and oral ena-
lapril till 9 months of life. His indomethacin was
stopped when his serum creatinine started increasing.
He progressed to Chronic Kidney Disease-Stage V at
1 year of life, and he succumbed to his illness at home.DISCUSSION
NPHS3 is a severe form of isolated congenital nephrotic
syndrome with rapid progression to terminal renal
failure. It is caused by a developmental rather than
structural podocyte dysfunction, as PLCE1 has been
implicated in glomerulogenesis. It is a major cause of
isolated diffuse mesangial sclerosis. Apart from NPHS21
Figure 1. Pedigree of the family.
Table 1. Laboratory investigations (4 mo of age)
Blood
BUN (mg/dl) 27 (7–20)
Creatinine (mg/dl) 0.5 (0.1–0.4)
Cholesterol (mg/dl) 264 (<200)
Albumin (g/dl) 2 (3.5–5.5)
Hb (g/dl) 12.2 (10–14)
TLC (109/l) 18.2 (5–15)
Platelet (109/l) 302 (150–400)
Urine
Protein/creatinine (mg/mg) 39.08 (<0.20)
Protein 3þ
Radiology
USG abdomen Bilateral renal parenchymal disease,
enhanced echogenicity, mild ascites
Data in parentheses represent normal range/values.
BUN, blood urea nitrogen; Hb, hemoglobin; TLC, total leukocyte count; USG,
ultrasonography.
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fantile and childhood-onset steroid-resistant nephrotic
syndrome.1–3 Causes of congenital nephrotic syndrome
are summarized in Table 2.
Mutations in PLCE1, WT1, and LAMB2 genes can
cause isolated diffuse mesangial sclerosis, with PLCE1
being the most common cause.3,4 It is proposed that
renal histopathologic patterns corroborate with the
kidney developmental stages at which PLCE1 activity
is required. Accordingly, diffuse mesangial sclerosis
occurs from a developmental arrest due to truncating
PLCE1 mutations, whereas focal segmental glomerulo-
sclerosis arises from low-level or dysfunctional PLCE1
in the less severe molecular defects.1–3
Therapy response in NPHS3 cases has been docu-
mented in a few cases, opening insights into genomic and
nongenomic effects of glucocorticoids on podocytes.2,4
Positional cloning has uncovered mutations in PLCE1
responsible for nephrotic syndrome that may be
reversible with immunosuppressants.2
Most intriguing aspects with PLCE1 mutations
are the genotype-phenotype variability and response
to immunosuppressants that have been documented2in various studies, reiterating the importance of
performing mutation analysis for all implicated
genes in congenital nephrotic syndrome. We however
did not use any immunosuppression in the case, in
view of rapid deterioration of renal function duringKidney International Reports (2016) -, -–-
Figure 2. Light microscopy (with special stains) and electron microscopy of the kidney biopsy. (a) Glomerulus with mesangial matrix expansion
and segmental sclerosis with proliferation of overlying podocytes is noted (hematoxylin and eosin [H&E] Ag, original magniﬁcation 400).
(b) Masson’s trichrome stain highlights the area of mesangial expansion along with proliferation of overlying podocytes (MT, original
magniﬁcation 400). (c) Silver-stained section reveals single linear core of renal biopsy with a small patch of tubular atrophy occupying 15% of
the sampled cortex (H&E Ag, original magniﬁcation 100). (d) Electron microscopic examination reveals diffuse foot process effacement. No
immune complex deposits noted (direct magniﬁcation 10,000).
Figure 3. Electropherogram showing a novel homozygous nonsense mutation (c.2290G>T, p.Glu764*) in exon 7 of the PLCE1 gene (phospholipase C,
epsilon1) in the index patient. Note that both parents are heterozygous carriers of the mutation (arrows). Nucleotide and protein numbering are based on
the PLCE1 isoform with the Genbank accession number NM_016341.3.
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Table 2. Causes of congenital nephrotic syndrome
Known mutations
 Nephrin (NPHS1) gene: classic “Finnish” type
 Podocin (NPHS2) gene
 Phospholipase C epsilon 1 (PLCE1) or NPHS3 gene
 Wilms tumor suppressor 1 (WT1) gene: Denys-Drash syndrome; isolated nephrotic
syndrome
 Laminin b2 (LAMB2) mutation: Pierson syndrome; isolated nephrotic syndrome
 Laminin b3 (LAMB3) mutation: Herlitz junctional epidermolysis bullosa
 Lim transcription factor 1b (LMXB1) mutation: nail-patella syndrome
Rare causes
 Galloway-Mowat syndrome
 Mitochondrial disorders
 Primary focal segmental glomerulosclerosis
 Congenital infections: syphilis, toxoplasma, malaria, cytomegalovirus, rubella,
hepatitis B, HIV
 Maternal systemic lupus erythematosus
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both clinical course and histology in NPHS3 are
subject to genotypic variability and that mutational
analysis is the most reliable diagnostic tool. Future4studies are needed to determine the clinical implica-
tions of NPHS3.DISCLOSURE
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